Moderna’s COVID-19 Vaccine Spikevax Receives Full FDA Approval for Children Aged 6 Months to 11 Years at “Increased Risk”

by Jim Hᴏft, TGP The U.S. Food and Drug Administration (FDA) has officially granted full approval to Moderna’s controversial mRNA COVID-19 vaccine, Spikevax, for children as young as 6 months old…[...]

Read More

Post-inflammatory Pigmentary Alteration (PIPA)-Like Disorder Following COVID-19 Vaccination

Larry M. Bush • Priscila M. Fiallo • Maria T. Vazquez-Pertejo, DOI: 10.7759/cureus.87222  Abstract SARS-CoV-2 (COVID-19) infection has been associated with various cutaneous manifestations presenting concomitantly with and following clinical resolution of active infection. Similarly,…[...]

Read More